Topics

Population Health

Feb 20 | Jeff Lagasse
Cancer outcomes vary substantially between populations defined by race/ethnicity, socioeconomic status, and…
Feb 19 | Jeff Lagasse
A potential byproduct of the ongoing physician burnout and shortages is a negative impact on the average lifespan,…
Feb 18 | Jeff Lagasse
The younger the patient, the more likely they are to opt for nontraditional healthcare…
Feb 15 | Beth Jones Sanborn
Marcia Conrad-Miller of CGI said if payers, providers, pharma work together on…
Doctors looking at a screen
Feb 14 | Jeff Lagasse
Pumping cash into a single, unified EHR can be cost prohibitive, so it helps to get a broad, macro view of the data…
Feb 12 | Susan Morse
Pharma wants to be a part of value-based programs in risk-based arrangements with payers.
Dr. Claire Pomeroy addresses the social determinants at HIMSS19.
Feb 12 | Susan Morse
Value-based care demands the switch to wellcare to raise outcomes and decrease costs, Claire Pomeroy says.
Feb 06 | Jeff Lagasse
LFS patients who received early cancer surveillance extended their lifetime, but incurred higher…
Feb 05 | Jeff Lagasse
The findings make a fiscal case for increasing prevention efforts among patents of all ages, not just…
Dr. Jonathan Austrian, medical director, Inpatient Clinical Informatics, at NYU Langone Health.
Feb 04 | Susan Morse
NYU Langone embedded a provider-facing screening question into the EHR admission process that was cosigned on admission and at discharge…

Pages